0
2023
Urinalysis Test Market

Urinalysis Test Market

by Product (Instruments, Consumables), by  Application (Disease screening, Pregnancy and fertility), by End user (Hospitals and clinics, Diagnostic laboratories, Home care): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A13240
Mar 2023 | Pages: 256
Tables: 125
Charts: 66
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Urinalysis Test Market Research, 2031

The global urinalysis test market size was valued for $3,194.13 million in 2021 and is estimated to reach $6,121.35 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031. Urinalysis, commonly referred to as a urine test, analyses the physical, chemical, and microscopic components of urine. Urine analysis involves various tests to check the urine contents for any abnormalities that indicate a medical condition or infection. It is used to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. Urinalysis involves examining the color, consistency, and composition of urine. It involves a number of tests that use a single urine sample to determine and measure the different substances that are present in urine. The urinalysis test includes various products, such as reagents, dipsticks, urine analyzers, and disposables.

The urinalysis test market witnessed a decline during the lockdown period owing to a decline in sales of urinalysis devices. In addition, delayed or canceled routine medical appointments and procedures due to concerns about the risk of exposure to the virus. This led to a reduction in the number of urinalysis tests performed in healthcare settings and negatively impacted the market growth.

Urinalysis Test Market

Market Dynamics

Growth & innovations in the medical devices industry for the manufacturing of urinalysis products such as urine analyzers, and pregnancy testing products, creates an opportunity for the urinalysis test market. The growth of the urinalysis test market is expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of chronic diseases such as diabetes, and surge in demand for urine analyzers, strips, and control solutions. For instance, according to the International Diabetes Federation (IDF), about 537 million adults were living with diabetes in 2021, across the globe. In addition, as per the same source, over 3 in 4 adults with diabetes live in low and middle-income countries such as India and China. Thus, the rise in number of people suffering from diabetes has increased the demand for urinalysis test and propel the market growth.

Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, and significant investments by government to improve healthcare infrastructure. E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. This further supports market growth. 

The demand for urinalysis test is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the market. Factors such as the rise in adoption of urine analyzers, reagents, pregnancy testing and disposables for disease screening and pregnancy tests which further drive the growth of the market. Furthermore, rise in consumer awareness related to preventive healthcare and ease of accessibility boosts the adoption of urinalysis products. 

In addition, screening programs are undertaken by governments for the early detection of diseases such as urological and renal disorders. For instance, according to the National Institute of Health (NIH), from February 2012 to March 2021, 12,497 school students from Pingyang, Cangnan, and Yongjia in Wenzhou were screened for urinalysis. Thus, a rise in the number of such programs is expected to drive the demand for urinalysis test industry .

Urinary tract infections are one of the most common types of infections, and they affect both men and women. Urinalysis tests are used to diagnose urinary tract infections, diabetes, other renal disorders, and the growing prevalence of these infections is driving the demand for urinalysis tests. Furthermore, there is a rise in demand for advanced devices for urinalysis due to the rise in prevalence of chronic diseases and the growing importance of preventive healthcare. These devices allow patients to monitor their health at home and reduce the need for frequent visits to healthcare providers. This has supported the market growth. Growing focus on preventive healthcare and early detection of medical conditions further supports the urinalysis test industry growth. 

The lack of skilled laboratory technicians, healthcare facilities, and advanced equipment in underdeveloped countries negatively impact the growth of the urinalysis test market. In many developing countries, there is a shortage of trained laboratory technicians who can perform urinalysis tests accurately and efficiently. This shortage can limit the capacity of healthcare facilities to provide urinalysis testing, which in turn reduces the demand for testing and limits the growth of the market. In addition, the low quality of healthcare services in many developing countries can also hinder the growth of the urinalysis test market.

COVID-19 pandemic had a negative effect on the urinalysis test market owing to decrease in demand for urinalysis devices which can be used to diagnose the urological and renal diseases. Due to the low hospitalization rate and dropping sales of urine analysis tests during the early stages of the COVID-19 pandemic, the market for urinalysis was little affected. Moreover, less hospitals visits for urinalysis tests during pandemic decreases the adoption of urinalysis devices and hampers the market growth. Furthermore, decline in the urological surgeries due to lockdown led to decrease in demand for urine analysis also hampers the market growth. However, the market is recovering after pandemic, and show stable urinalysis test market growth in the future owing to rise in cases of urological disorders.

Segmental Overview

The urinalysis test market is segmented into product, application, end user, and region. By product, the market is categorized into instruments and consumables. On the basis of application, the market is segregated into disease screening and pregnancy & fertility. By end user, the market is classified into hospitals & clinics, diagnostic laboratories, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Product 

The urinalysis market is segmented into instruments and consumables. The consumables segment dominated the urinalysis test market size in 2021 and is also expected to witness significant growth during the forecast period. This is attributed to a rise in demand for advanced urinary consumables as they are easy to use, convenient to handle and can be stored for longer duration without compromising its quality. For instance, Bio-Rad Laboratories, Inc. a global provider of life science research and clinical diagnostics products, offer qUAntify Advance Control urinalysis product, which is an independent quality control used to monitor the precision of laboratory urinalysis test procedures, improve the efficiency, and reduce the risk of error. Thus, advancements in technology to improve the accuracy, and convenience of urinalysis testing, leading to increase in demand for urinalysis consumables, which is expected to drive the segment growth in urinalysis test market forecast .

Urinalysis Test Market

By Application

The urinalysis test market is segregated into disease screening and pregnancy & fertility. The disease screening segment dominated the urinalysis test market share in 2021 and is also expected to witness significant growth during the forecast period. Urinalysis tests help in the early detection and screening of various diseases, including urinary tract infections (UTIs), kidney diseases, and diabetes, which supports the segment growth.

[APPLICATIONGRAPH]

By End User

The urinalysis test market is classified into hospitals & clinics, diagnostic laboratories, and home care. The diagnostic laboratories held the largest urinalysis test market share in 2021 and is also expected to witness highest CAGR during the forecast period. This is attributed to the high adoption of urinalysis products in hospitals and clinics. In addition, urinalysis provides quick and relatively accurate results, making it a valuable tool for healthcare providers in diagnostic laboratories to diagnose and treat various conditions which led to increase in demand for urinalysis devices in diagnostic laboratories.  

Urinalysis Test Market

By Region

The urinalysis test market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.  North America accounted for a major share of the urinalysis test market in 2021 and is expected to maintain its dominance during the forecast period.

Advancement in manufacturing technology for urinalysis products in the region drives the growth of the market. Diabetes is a prevalent chronic condition in North America, and it is associated with abnormal urine composition. For instance, as per the data published by Endocrine Society, in January 2022, it was estimated that around 33% of adults aged 65 or older had diabetes. Urinalysis is a useful diagnostic tool for detecting early signs of diabetes-related kidney damage, which is driving the demand for urinalysis tests in this region. Furthermore, high purchasing power, and rise in adoption rate of urinalysis devices are expected to drive the market growth.

Urinalysis Test Market

Moreover, rise in spending by population in countries such as the U.S. and Canada further leads to growth of the industry. Personal healthcare expenditure in the U.S, as stated by the Centers for Disease Control and Prevention, was estimated to increase by an annual percent change of 4.6% in 2019 to $3.6 trillion or $11,172 per capita. This is attributed to substantial demand for novel medical technologies and healthcare assistance in North America. 

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to presence of medical devices companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Furthermore, rise in the prevalence of chronic diseases such as diabetes, kidney disease, and urinary tract infections and urinalysis tests are commonly used to diagnose and monitor these conditions, which is driving the growth of the urinalysis test market in the region. In addition, growing awareness about the importance of preventive healthcare in the Asia-Pacific region is driving the demand for diagnostic tests, including urinalysis tests, to detect health problems at an early stage.

Asia-Pacific offers profitable opportunities for key players operating in the urinalysis test market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rise in disposable incomes, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunity for UA test market new entrants in this region.  

Competition Analysis

Competitive analysis and profiles of the players in the urinalysis market, such as Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Sysmex Corporation, and 77 Elektronika Kft. are provided in this report. 
Key players have adopted agreement as key developmental strategy to improve the product portfolio of the UA test market.  

Recent Agreements in the Urinalysis Test Market

•    In August 2020, Sysmex America, Inc., a part of Sysmex Corporation has announced an exclusive agreement with Siemens Healthineers that grants North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use.
•    In January 2020, Sysmex Corporation has reached an agreement to invest in Astrego Diagnostics. In this agreement, Astrego was developing new urinalysis solutions for the primary care business.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the urinalysis test market analysis from 2021 to 2031 to identify the prevailing urinalysis test market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the urinalysis test market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global urinalysis test market trends, key players, market segments, application areas, and market growth strategies.

Urinalysis Test Market Report Highlights

Aspects Details
Market Size By 2031 USD 6.1 billion
Growth Rate CAGR of 6.7%
Forecast period 2021 - 2031
Report Pages 256
By Product
  • Instruments
  • Consumables
By  Application
  • Disease screening
  • Pregnancy and fertility
By End user
  • Hospitals and clinics
  • Diagnostic laboratories
  • Home care
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players ACON Laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Bio-Rad Laboratories, Inc. , Siemens AG, Cardinal Health Inc., ARKRAY, Inc., Sysmex Corporation, Abbott Laboratories, 77 Elektronika Kft

Analyst Review

This section provides various opinions of top-level CXOs in the global urinalysis test market. According to the insights of CXOs, the global urinalysis test market is expected to exhibit high growth potential attributable to rise in prevalence of various disease and surge in awareness toward early diagnosis and treatment. However, shortage of skilled professionals in some regions limit the growth of the urinalysis test market.? 

CXOs further added that rise in incidences of chronic diseases such as diabetes, hypertension, and kidney diseases and development of advanced urinalysis testing technologies, such as automated urine analyzers drive the market growth.?? 

Furthermore, North America was the major shareholder in 2021, in terms of revenue, owing to rise in incidences of chronic disease, higher health awareness along with developed healthcare infrastructure drives market growth in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in chronic disease and growth in urinalysis test along with growing awareness for early detection of disease.

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Bargaining power of suppliers

      • 3.3.2. Bargaining power of buyers

      • 3.3.3. Threat of substitutes

      • 3.3.4. Threat of new entrants

      • 3.3.5. Intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Rise in prevalence of chronic diseases
        • 3.4.1.2. Increase in the geriatric population
        • 3.4.1.3. Increase in awareness about the importance of regular health checkups

      • 3.4.2. Restraints

        • 3.4.2.1. Lack of skilled laboratory technician

      • 3.4.3. Opportunities

        • 3.4.3.1. Technological innovations in urine analyzers

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: URINALYSIS TEST MARKET, BY PRODUCT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Instruments

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Consumables

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

  • CHAPTER 5: URINALYSIS TEST MARKET, BY  APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Disease screening

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Pregnancy and fertility

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: URINALYSIS TEST MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals and clinics

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Diagnostic laboratories

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Home care

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: URINALYSIS TEST MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Product

      • 7.2.3. Market size and forecast, by  Application

      • 7.2.4. Market size and forecast, by End user

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Product
          • 7.2.5.1.3. Market size and forecast, by  Application
          • 7.2.5.1.4. Market size and forecast, by End user
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Product
          • 7.2.5.2.3. Market size and forecast, by  Application
          • 7.2.5.2.4. Market size and forecast, by End user
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Product
          • 7.2.5.3.3. Market size and forecast, by  Application
          • 7.2.5.3.4. Market size and forecast, by End user
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Product

      • 7.3.3. Market size and forecast, by  Application

      • 7.3.4. Market size and forecast, by End user

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Product
          • 7.3.5.1.3. Market size and forecast, by  Application
          • 7.3.5.1.4. Market size and forecast, by End user
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Product
          • 7.3.5.2.3. Market size and forecast, by  Application
          • 7.3.5.2.4. Market size and forecast, by End user
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Product
          • 7.3.5.3.3. Market size and forecast, by  Application
          • 7.3.5.3.4. Market size and forecast, by End user
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Product
          • 7.3.5.4.3. Market size and forecast, by  Application
          • 7.3.5.4.4. Market size and forecast, by End user
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Product
          • 7.3.5.5.3. Market size and forecast, by  Application
          • 7.3.5.5.4. Market size and forecast, by End user
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Product
          • 7.3.5.6.3. Market size and forecast, by  Application
          • 7.3.5.6.4. Market size and forecast, by End user
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Product

      • 7.4.3. Market size and forecast, by  Application

      • 7.4.4. Market size and forecast, by End user

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Product
          • 7.4.5.1.3. Market size and forecast, by  Application
          • 7.4.5.1.4. Market size and forecast, by End user
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Product
          • 7.4.5.2.3. Market size and forecast, by  Application
          • 7.4.5.2.4. Market size and forecast, by End user
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Product
          • 7.4.5.3.3. Market size and forecast, by  Application
          • 7.4.5.3.4. Market size and forecast, by End user
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Product
          • 7.4.5.4.3. Market size and forecast, by  Application
          • 7.4.5.4.4. Market size and forecast, by End user
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Product
          • 7.4.5.5.3. Market size and forecast, by  Application
          • 7.4.5.5.4. Market size and forecast, by End user
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Product
          • 7.4.5.6.3. Market size and forecast, by  Application
          • 7.4.5.6.4. Market size and forecast, by End user
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Product

      • 7.5.3. Market size and forecast, by  Application

      • 7.5.4. Market size and forecast, by End user

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Product
          • 7.5.5.1.3. Market size and forecast, by  Application
          • 7.5.5.1.4. Market size and forecast, by End user
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Product
          • 7.5.5.2.3. Market size and forecast, by  Application
          • 7.5.5.2.4. Market size and forecast, by End user
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Product
          • 7.5.5.3.3. Market size and forecast, by  Application
          • 7.5.5.3.4. Market size and forecast, by End user
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Product
          • 7.5.5.4.3. Market size and forecast, by  Application
          • 7.5.5.4.4. Market size and forecast, by End user
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. ARKRAY, Inc.

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

    • 9.2. Cardinal Health Inc.

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

    • 9.3. Danaher Corporation

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. Siemens AG

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Sysmex Corporation

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. F. Hoffmann-La Roche Ltd.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. Bio-Rad Laboratories, Inc. 

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

    • 9.8. ACON Laboratories, Inc.

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

    • 9.9. 77 Elektronika Kft

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

    • 9.10. Abbott Laboratories

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

  • LIST OF TABLES

  • TABLE 01. GLOBAL URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 02. URINALYSIS TEST MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
    TABLE 03. URINALYSIS TEST MARKET FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
    TABLE 04. GLOBAL URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 05. URINALYSIS TEST MARKET FOR DISEASE SCREENING, BY REGION, 2021-2031 ($MILLION)
    TABLE 06. URINALYSIS TEST MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2021-2031 ($MILLION)
    TABLE 07. GLOBAL URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 08. URINALYSIS TEST MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 09. URINALYSIS TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
    TABLE 10. URINALYSIS TEST MARKET FOR HOME CARE, BY REGION, 2021-2031 ($MILLION)
    TABLE 11. URINALYSIS TEST MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. NORTH AMERICA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 13. NORTH AMERICA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 14. NORTH AMERICA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 15. NORTH AMERICA URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 16. U.S. URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 17. U.S. URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 18. U.S. URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 19. CANADA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 20. CANADA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 21. CANADA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 22. MEXICO URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 23. MEXICO URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 24. MEXICO URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 25. EUROPE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 26. EUROPE URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 27. EUROPE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 28. EUROPE URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 29. GERMANY URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 30. GERMANY URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 31. GERMANY URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 32. FRANCE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 33. FRANCE URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 34. FRANCE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 35. UK URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 36. UK URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 37. UK URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 38. ITALY URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 39. ITALY URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 40. ITALY URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 41. SPAIN URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 42. SPAIN URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 43. SPAIN URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 44. REST OF EUROPE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 45. REST OF EUROPE URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 46. REST OF EUROPE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 47. ASIA-PACIFIC URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 48. ASIA-PACIFIC URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 49. ASIA-PACIFIC URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 50. ASIA-PACIFIC URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 51. JAPAN URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 52. JAPAN URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 53. JAPAN URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 54. CHINA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 55. CHINA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 56. CHINA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 57. INDIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 58. INDIA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 59. INDIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 60. AUSTRALIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 61. AUSTRALIA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 62. AUSTRALIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 63. SOUTH KOREA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 64. SOUTH KOREA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 65. SOUTH KOREA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 66. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 67. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 68. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 69. LAMEA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 70. LAMEA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 71. LAMEA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 72. LAMEA URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 73. BRAZIL URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 74. BRAZIL URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 75. BRAZIL URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 76. SAUDI ARABIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 77. SAUDI ARABIA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 78. SAUDI ARABIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 79. SOUTH AFRICA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 80. SOUTH AFRICA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 81. SOUTH AFRICA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 82. REST OF LAMEA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
    TABLE 83. REST OF LAMEA URINALYSIS TEST MARKET, BY  APPLICATION, 2021-2031 ($MILLION)
    TABLE 84. REST OF LAMEA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 85. ARKRAY, INC.: KEY EXECUTIVES
    TABLE 86. ARKRAY, INC.: COMPANY SNAPSHOT
    TABLE 87. ARKRAY, INC.: PRODUCT SEGMENTS
    TABLE 88. ARKRAY, INC.: PRODUCT PORTFOLIO
    TABLE 89. CARDINAL HEALTH INC.: KEY EXECUTIVES
    TABLE 90. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
    TABLE 91. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
    TABLE 92. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
    TABLE 93. DANAHER CORPORATION: KEY EXECUTIVES
    TABLE 94. DANAHER CORPORATION: COMPANY SNAPSHOT
    TABLE 95. DANAHER CORPORATION: PRODUCT SEGMENTS
    TABLE 96. DANAHER CORPORATION: PRODUCT PORTFOLIO
    TABLE 97. SIEMENS AG: KEY EXECUTIVES
    TABLE 98. SIEMENS AG: COMPANY SNAPSHOT
    TABLE 99. SIEMENS AG: PRODUCT SEGMENTS
    TABLE 100. SIEMENS AG: PRODUCT PORTFOLIO
    TABLE 101. SYSMEX CORPORATION: KEY EXECUTIVES
    TABLE 102. SYSMEX CORPORATION: COMPANY SNAPSHOT
    TABLE 103. SYSMEX CORPORATION: PRODUCT SEGMENTS
    TABLE 104. SYSMEX CORPORATION: PRODUCT PORTFOLIO
    TABLE 105. SYSMEX CORPORATION: KEY STRATERGIES
    TABLE 106. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
    TABLE 107. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
    TABLE 108. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
    TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
    TABLE 110. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
    TABLE 111. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
    TABLE 112. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
    TABLE 113. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
    TABLE 114. ACON LABORATORIES, INC.: KEY EXECUTIVES
    TABLE 115. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
    TABLE 116. ACON LABORATORIES, INC.: PRODUCT SEGMENTS
    TABLE 117. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
    TABLE 118. 77 ELEKTRONIKA KFT: KEY EXECUTIVES
    TABLE 119. 77 ELEKTRONIKA KFT: COMPANY SNAPSHOT
    TABLE 120. 77 ELEKTRONIKA KFT: PRODUCT SEGMENTS
    TABLE 121. 77 ELEKTRONIKA KFT: PRODUCT PORTFOLIO
    TABLE 122. ABBOTT LABORATORIES: KEY EXECUTIVES
    TABLE 123. ABBOTT LABORATORIES: COMPANY SNAPSHOT
    TABLE 124. ABBOTT LABORATORIES: PRODUCT SEGMENTS
    TABLE 125. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 01. URINALYSIS TEST MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF URINALYSIS TEST MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN URINALYSIS TEST MARKET (2022-2031)
    FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
    FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
    FIGURE 06. MODERATE THREAT OF SUBSTITUTES
    FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
    FIGURE 08. MODERATE INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALURINALYSIS TEST MARKET
    FIGURE 10. URINALYSIS TEST MARKET, BY PRODUCT, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR INSTRUMENTS, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR CONSUMABLES, BY COUNTRY 2021-2031(%)
    FIGURE 13. URINALYSIS TEST MARKET, BY  APPLICATION, 2021(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR DISEASE SCREENING, BY COUNTRY 2021-2031(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR PREGNANCY AND FERTILITY, BY COUNTRY 2021-2031(%)
    FIGURE 16. URINALYSIS TEST MARKET, BY END USER, 2021(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2021-2031(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR HOME CARE, BY COUNTRY 2021-2031(%)
    FIGURE 20. URINALYSIS TEST MARKET BY REGION, 2021
    FIGURE 21. U.S. URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 22. CANADA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 23. MEXICO URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 24. GERMANY URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 25. FRANCE URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 26. UK URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 27. ITALY URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 28. SPAIN URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 29. REST OF EUROPE URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 30. JAPAN URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 31. CHINA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 32. INDIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 33. AUSTRALIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 34. SOUTH KOREA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 35. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 36. BRAZIL URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 37. SAUDI ARABIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 38. SOUTH AFRICA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 39. REST OF LAMEA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
    FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 44. COMPETITIVE DASHBOARD
    FIGURE 45. COMPETITIVE HEATMAP: URINALYSIS TEST MARKET
    FIGURE 46. TOP PLAYER POSITIONING, 2021
    FIGURE 47. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 48. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 49. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 50. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
    FIGURE 51. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 52. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 53. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 54. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 55. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 56. SYSMEX CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 57. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 59. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 60. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 61. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
    FIGURE 62. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 63. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 64. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
    FIGURE 65. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 66. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Growth & innovations in the medical devices industry for the manufacturing of urinalysis products along with increasing diagnosis are the upcoming trends of urinalysis test market.

A. Disease screening is the leading application of urinalysis test market.

A. North America is the largest regional market for urinalysis test.

A. The urinalysis test market valued for $3,194.13 million in 2021 and is estimated to reach $6,121.35 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.

A. Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Sysmex Corporation, and 77 Elektronika Kft. are the top companies to hold the market share in urinalysis test.

A. 2021 is the base year of urinalysis test market.

A. 2022 to 2031 are the forecast years of urinalysis test market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Urinalysis Test Market

Start reading instantly.
This Report and over 68,131+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Mar 2024 - Mar 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers